Clinical trial of subsequent injection of HVJ-E to those patients who enrolled in the clinical trial of 'Phase I/II clinical trial to assess safety and efficacy of intratumoural and subcutaneous injection of HVJ-E to castration resistant prostate cancer patients' [EXTENSION OF 700205839]
Latest Information Update: 22 Jun 2013
At a glance
- Drugs GEN 0101 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 22 Jun 2013 New trial record